Sanara MedTech Inc.

Sanara MedTech Inc. operates within the SIC 3841 Orthopedic, Prosthetic & Surgical Appliances & Supplies space, offering a suite of joint reconstruction implants, tissue repair solutions, and surgical instrumentation designed to support orthopedic surgeons, hospital systems, and outpatient specialty clinics. The company balances innovation—often incorporating advanced biomaterials and customizable surgical guides—with the rigorous compliance demands of FDA regulation, Medicare reimbursement policies, and evolving implant surveillance requirements. Sanara’s supply chain initiatives and quality systems underscore how it serves high-volume joint replacement programs and trauma centers while managing the inherent product liability, clinical performance, and raw-material cost risks that come with implantable devices. Investors can also assess the company’s recent performance and disclosures in the latest Form 10-Q filed in November 2025. CIK 714256 and ticker SMTI highlight Sanara’s public transparency, and the page invites readers to view live SEC filings on Earnings Feed for continual updates.

Source: Earnings Feed research · last updated 11/24/2025